What are the most common side effects of TRANYLCYPROMINE?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for TRANYLCYPROMINE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is TRANYLCYPROMINE the same as Tranylcypromine?

Tranylcypromine is a brand name for TRANYLCYPROMINE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

TRANYLCYPROMINE

Q: What is TRANYLCYPROMINE used for?

TRANYLCYPROMINE (brand name Tranylcypromine) is a MAOI indicated for and the need for dietary restrictions [see Contraindications (4), Warnings and Precautions (5), and the need for dietary restrictions ( 1.

Q: How does TRANYLCYPROMINE work?

TRANYLCYPROMINE works through the following mechanism: 12.1 Mechanism of Action The mechanism of action of tranylcypromine tablets as an antidepressant is not fully understood, but is presumed to be linked to potentiation of monoamine neurotransmitter activity in the central nervous system (CNS) resulting from its irreversible inhibition of the enzyme monoamine oxidase (MAO)..

MAOI

Brand names: Tranylcypromine, Parnate

Oral

Mechanism of Action

12.1 Mechanism of Action The mechanism of action of tranylcypromine tablets as an antidepressant is not fully understood, but is presumed to be linked to potentiation of monoamine neurotransmitter activity in the central nervous system (CNS) resulting from its irreversible inhibition of the enzyme monoamine oxidase (MAO).

Indications

and the need for dietary restrictions [see Contraindications (4)

Warnings and Precautions (5)

and the need for dietary restrictions ( 1

7 )

Contraindications

• 4 CONTRAINDICATIONS • Concomitant use or use in rapid succession with other MAOIs
• selective serotonin reuptake inhibitors
• serotonin and norepinephrine reuptake inhibitors
• tricyclic antidepressants
• sympathomimetic drugs

FDA Warnings

5 WARNINGS AND PRECAUTIONS • Activation of Mania/Hypomania : May be precipitated by antidepressant treatment in patients with bipolar disorder
There was considerable variation in risk of suicidal thoughts and behaviors among drugs, but there was an increased risk identified in young patients for most drugs studied
There were differences in absolute risk of suicidal thoughts and behaviors across the different indications, with the highest incidence in patients with MDD
However, there is substantial evidence from placebo-controlled maintenance trials in adults with MDD that antidepressants delay the recurrence of depression and that depression itself is a risk factor for suicidal thoughts and behaviors

Known Side Effects

10 documented side effects by frequency

Drug Not Working

>10%

Depression

1-10%

Headache

1-10%

Insomnia

1-10%

Nausea

1-10%

High Blood Pressure

1-10%

Fatigue

1-10%

Anxiety

0.1-1%

Excessive Sweating

0.1-1%

Dizziness

0.1-1%

Community Discussions

No community discussions found for TRANYLCYPROMINE yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → TRANYLCYPROMINE openFDA label JSON → TRANYLCYPROMINE FAERS adverse-event reports → TRANYLCYPROMINE ClinicalTrials.gov → completed Phase 2+ trials of TRANYLCYPROMINE

Compare With

1 available comparisons

vs Phenelzine

Formulations

Dosage Forms

Tablet

Route

Oral